Competition is coming for a top drug

Today in our Pulse Check podcast, Lauren Gardner talks with Megan Messerly about the introduction of biosimilars next year to compete with Humira, the anti-inflammatory used to treat arthritis that has been the best-selling drug in America. Competition could reduce prices for consumers, but that’s not certain. Lauren explains how it could play out.  Learn more about your ad choices. Visit megaphone.fm/adchoices